Casdin Capital, LLC 13D and 13G filings for MaxCyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | Casdin Capital, LLC | 0 0.000% | -9,220,000 (Position Closed) | Filing |
| 2023-01-10 4:48 pm Sale | 2023-01-05 | 13G | MaxCyte, Inc. MXCT | Casdin Capital, LLC | 9,220,000 9.020% | -4,751,334 (-34.01%) | Filing |
| 2021-08-03 5:16 pm Purchase | 2021-07-29 | 13G | MaxCyte, Inc. MXCT | Casdin Capital, LLC | 13,971,334 14.200% | 13,971,334 (New Position) | Filing |